Gain Therapeutics, Inc. financial data

Symbol
GANX on Nasdaq
Industry
Pharmaceutical Preparations
Location
4800 Hampden Lane, Suite 200, Bethesda, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 303 % -11.8%
Debt-to-equity 59.3 % +22.6%
Return On Equity -204 % -20.3%
Return On Assets -128 % -12.1%
Operating Margin -7.74K % -1.45%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.5M shares +105%
Common Stock, Shares, Outstanding 26M shares +103%
Entity Public Float 56.6M USD +45.9%
Common Stock, Value, Issued 2.6K USD +103%
Weighted Average Number of Shares Outstanding, Basic 26.5M shares +109%
Weighted Average Number of Shares Outstanding, Diluted 26.5M shares +109%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 55.2K USD +22.6%
Revenue from Contract with Customer, Excluding Assessed Tax 55.2K USD +47%
Research and Development Expense 11.9M USD +4.55%
General and Administrative Expense 9.49M USD -14.1%
Operating Income (Loss) -21.4M USD +4.38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -21.3M USD +3.42%
Income Tax Expense (Benefit) 46.6K USD -67.4%
Net Income (Loss) Attributable to Parent -21.4M USD +3.83%
Earnings Per Share, Basic -1.1 USD/shares +39.2%
Earnings Per Share, Diluted -1.1 USD/shares +39.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12M USD +182%
Marketable Securities, Current 2.02M USD -82.9%
Cash, Cash Equivalents, and Short-term Investments 12.7M USD
Assets, Current 13.7M USD +3.77%
Property, Plant and Equipment, Net 120K USD -6.11%
Operating Lease, Right-of-Use Asset 282K USD -42.6%
Assets 14.4M USD +1.9%
Accounts Payable, Current 1.1M USD -20.2%
Accrued Liabilities, Current 674K USD -49.6%
Liabilities, Current 4.59M USD -20.3%
Operating Lease, Liability, Noncurrent 96.2K USD -63.5%
Liabilities 5.46M USD -19.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 243K USD +168%
Retained Earnings (Accumulated Deficit) -60.8M USD
Stockholders' Equity Attributable to Parent 8.91M USD +21.5%
Liabilities and Equity 14.4M USD +1.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.59M USD +15%
Net Cash Provided by (Used in) Financing Activities -146K USD -119%
Net Cash Provided by (Used in) Investing Activities 3.02M USD +43.3%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 26M shares +103%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.16M USD +12.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12.1M USD +181%
Deferred Tax Assets, Valuation Allowance 12M USD +27.5%
Deferred Tax Assets, Gross 12.1M USD +27.4%
Operating Lease, Liability 275K USD -44.4%
Depreciation 8K USD 0%
Payments to Acquire Property, Plant, and Equipment 7.83K USD -72.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.2M USD +2.82%
Lessee, Operating Lease, Liability, to be Paid 279K USD
Property, Plant and Equipment, Gross 241K USD +17%
Operating Lease, Liability, Current 179K USD -22.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.01 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.55K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 86.1M USD +36%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 175K USD -22.2%
Depreciation, Depletion and Amortization 20.5K USD +6.68%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 235K USD -3.4%
Share-based Payment Arrangement, Expense 2.58M USD -20.9%
Operating Leases, Future Minimum Payments, Due in Three Years 57.9K USD -64.9%
Operating Leases, Future Minimum Payments Due 467K USD -31.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%